Table 6.
Therapy used in osteosarcoma patients | ||||
---|---|---|---|---|
COSS 96 | 12.50% | 31.25% | 18.25% | 62.00% |
EWING 99 | 0% | 0% | 6.25% | 6% |
No treat | 6.25% | 6.25% | 6.25% | 18.75% |
MTX | 0% | 6.25% | 0% | 6% |
Daunobl. | 0% | 6.25% | 0% | 6% |
Therapy used in Ewing sarcoma patients | ||||
---|---|---|---|---|
EWING 99 | 33.33% | 16.66% | 16.66% | 66.65% |
VAIA | 16.66% | 0% | 0% | 16.66% |
EVAIA | 0% | 5.55% | 5.55% | 11% |
COSS 96 | 0% | 0% | 5.55% | 6% |
Radiotherapy | 22.22% | 0% | 0% | 22.22% |
BMT | 0% | 11.11% | 0% | 11% |